PortalPublikationenManagement of Cytokine Release Syndrome (CRS) and HLH

Management of Cytokine Release Syndrome (CRS) and HLH

Standard

Management of Cytokine Release Syndrome (CRS) and HLH. / Ayuketang, Francis Ayuk; Jäger, Ulrich.

The EBMT/EHA CAR-T Cell Handbook. Hrsg. / Nicolaus Kröger; John Gribben; Christian Chabannon; Ibrahim Yakoub-Agha; Hermann Einsele. 1. Aufl. Cham : Springer International Publishing, 2022. S. 135-139.

Publikationen: SCORING: Beitrag in Buch/Sammelwerk › Kapitel › Forschung

Harvard

Ayuketang, FA & Jäger, U 2022, Management of Cytokine Release Syndrome (CRS) and HLH. in N Kröger, J Gribben, C Chabannon, I Yakoub-Agha & H Einsele (Hrsg.), The EBMT/EHA CAR-T Cell Handbook. 1 Aufl., Springer International Publishing, Cham, S. 135-139. https://doi.org/10.1007/978-3-030-94353-0_26

APA

Ayuketang, F. A., & Jäger, U. (2022). Management of Cytokine Release Syndrome (CRS) and HLH. in N. Kröger, J. Gribben, C. Chabannon, I. Yakoub-Agha, & H. Einsele (Hrsg.), The EBMT/EHA CAR-T Cell Handbook (1 Aufl., S. 135-139). Springer International Publishing. https://doi.org/10.1007/978-3-030-94353-0_26

Vancouver

Ayuketang FA, Jäger U. Management of Cytokine Release Syndrome (CRS) and HLH. in Kröger N, Gribben J, Chabannon C, Yakoub-Agha I, Einsele H, Hrsg., The EBMT/EHA CAR-T Cell Handbook. 1 Aufl. Cham: Springer International Publishing. 2022. S. 135-139 https://doi.org/10.1007/978-3-030-94353-0_26

Bibtex

@inbook{27e494941ae54cc4908606ba4a2da51a,
title = "Management of Cytokine Release Syndrome (CRS) and HLH",
abstract = "Cytokine release syndrome (CRS) is caused by a rapid and mild to massive release of cytokines from immune cells involved in immune reactions, particularly after immunotherapy. The frequency and severity of CRS after CAR-T cell therapy varies between products (any grade: 37–93%, G3/4: 1–23%) (Neelapu et al. 2017; Schuster et al. 2019; Abramson et al. 2020).",
author = "Ayuketang, {Francis Ayuk} and Ulrich J{\"a}ger",
year = "2022",
doi = "10.1007/978-3-030-94353-0_26",
language = "English",
isbn = "978-3-030-94352-3",
pages = "135--139",
editor = "Nicolaus Kr{\"o}ger and John Gribben and Christian Chabannon and Ibrahim Yakoub-Agha and Hermann Einsele",
booktitle = "The EBMT/EHA CAR-T Cell Handbook",
publisher = "Springer International Publishing",
address = "Switzerland",
edition = "1",

}

RIS

TY - CHAP

T1 - Management of Cytokine Release Syndrome (CRS) and HLH

AU - Ayuketang, Francis Ayuk

AU - Jäger, Ulrich

PY - 2022

Y1 - 2022

N2 - Cytokine release syndrome (CRS) is caused by a rapid and mild to massive release of cytokines from immune cells involved in immune reactions, particularly after immunotherapy. The frequency and severity of CRS after CAR-T cell therapy varies between products (any grade: 37–93%, G3/4: 1–23%) (Neelapu et al. 2017; Schuster et al. 2019; Abramson et al. 2020).

AB - Cytokine release syndrome (CRS) is caused by a rapid and mild to massive release of cytokines from immune cells involved in immune reactions, particularly after immunotherapy. The frequency and severity of CRS after CAR-T cell therapy varies between products (any grade: 37–93%, G3/4: 1–23%) (Neelapu et al. 2017; Schuster et al. 2019; Abramson et al. 2020).

U2 - 10.1007/978-3-030-94353-0_26

DO - 10.1007/978-3-030-94353-0_26

M3 - Chapter

SN - 978-3-030-94352-3

SP - 135

EP - 139

BT - The EBMT/EHA CAR-T Cell Handbook

A2 - Kröger, Nicolaus

A2 - Gribben, John

A2 - Chabannon, Christian

A2 - Yakoub-Agha, Ibrahim

A2 - Einsele, Hermann

PB - Springer International Publishing

CY - Cham

ER -